[DPHARMA] YoY Quarter Result on 30-Jun-2017 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 12.01%
YoY- 114.37%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 143,331 145,466 123,991 117,049 79,135 56,308 40,623 23.36%
PBT 19,391 18,316 12,915 12,642 7,723 8,407 10,107 11.46%
Tax -4,662 -4,400 -2,576 -3,001 -3,782 -2,559 -2,594 10.25%
NP 14,729 13,916 10,339 9,641 3,941 5,848 7,513 11.86%
-
NP to SH 14,729 13,916 10,339 9,653 4,503 5,848 7,513 11.86%
-
Tax Rate 24.04% 24.02% 19.95% 23.74% 48.97% 30.44% 25.67% -
Total Cost 128,602 131,550 113,652 107,408 75,194 50,460 33,110 25.35%
-
Net Worth 581,725 503,029 209,983 463,071 446,334 189,815 179,145 21.66%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 3,421 6,618 4,199 6,973 6,973 5,582 5,554 -7.75%
Div Payout % 23.23% 47.56% 40.62% 72.25% 154.87% 95.47% 73.94% -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 581,725 503,029 209,983 463,071 446,334 189,815 179,145 21.66%
NOSH 684,383 661,881 650,902 278,959 278,959 139,570 138,872 30.41%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 10.28% 9.57% 8.34% 8.24% 4.98% 10.39% 18.49% -
ROE 2.53% 2.77% 4.92% 2.08% 1.01% 3.08% 4.19% -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 20.94 21.98 44.29 41.96 28.37 40.34 29.25 -5.41%
EPS 2.15 2.07 1.59 3.46 1.41 4.19 5.41 -14.24%
DPS 0.50 1.00 1.50 2.50 2.50 4.00 4.00 -29.26%
NAPS 0.85 0.76 0.75 1.66 1.60 1.36 1.29 -6.71%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 14.90 15.12 12.89 12.17 8.23 5.85 4.22 23.37%
EPS 1.53 1.45 1.07 1.00 0.47 0.61 0.78 11.87%
DPS 0.36 0.69 0.44 0.72 0.72 0.58 0.58 -7.63%
NAPS 0.6047 0.5229 0.2183 0.4814 0.464 0.1973 0.1862 21.66%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 1.62 1.37 1.30 2.25 2.04 2.65 2.97 -
P/RPS 7.74 6.23 2.94 5.36 7.19 6.57 10.15 -4.41%
P/EPS 75.27 65.16 35.20 65.02 126.38 63.25 54.90 5.39%
EY 1.33 1.53 2.84 1.54 0.79 1.58 1.82 -5.08%
DY 0.31 0.73 1.15 1.11 1.23 1.51 1.35 -21.72%
P/NAPS 1.91 1.80 1.73 1.36 1.28 1.95 2.30 -3.04%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 26/08/14 -
Price 3.15 1.41 1.08 2.03 2.14 2.40 3.37 -
P/RPS 15.04 6.42 2.44 4.84 7.54 5.95 11.52 4.53%
P/EPS 146.36 67.06 29.25 58.66 132.57 57.28 62.29 15.28%
EY 0.68 1.49 3.42 1.70 0.75 1.75 1.61 -13.36%
DY 0.16 0.71 1.39 1.23 1.17 1.67 1.19 -28.40%
P/NAPS 3.71 1.86 1.44 1.22 1.34 1.76 2.61 6.03%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment